BRIMONIDINE TARTRATE; TIMOLOL MALEATE | A091087 | SANDOZ INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Allergan Sales, LLC v. Sandoz, Inc. 4 patentsANDA 091087brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5% | E.D. Tex. | 2015-03-09 | Terminated 2016-12-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.88
per ml
Lowest NADAC/Unit
$2.10
per ml
Brand NDCs
0
Generic NDCs
3
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00781718675BRIMONIDINE-TIMOLOL 0.2%-0.5% | $2.88 | ML | Generic | — | 2026-06-17 |
| 00781718670BRIMONIDINE-TIMOLOL 0.2%-0.5% | $2.60 | ML | Generic | — | 2026-06-17 |
| 00781718685BRIMONIDINE-TIMOLOL 0.2%-0.5% | $2.10 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.